Life sciences practice leaders expect an uptick in M&A work under the new Trump administration, while litigators in the industry expect work to remain relatively steady. As is the case in other ...

Discover how the latest end-to-end solutions for cell culture, preservation, and analysis set life science researchers up for success.

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. However, I believe their SLS009 candidate as a CDK9 inhibitor further gives the stock broad AML ...

Oct. 20 (UPI) --Anthropic on Monday announced a new service called Claude of Life Sciences that uses artificial intelligence in efforts to advance scientific discovery. This is the San Francisco-based ...